The $15 billion ad-powered AI startup your doctor may already be using
Text
From Ars Technica
OpenEvidence is booming despite questions about accuracy and ads.
More in Health & science
“AI psychosis” appears rare but real, and first-episode patients may be most vulnerable, study suggests
Microsoft’s Mustafa Suleyman says its AI outperforms doctors on hard cases as he chases ‘medical superintelligence’
Microsoft says its AI tool is better than doctors at diagnosing conditions
.gif)